Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04918095 · ClinicalTrials.gov registry record
CareCOPD - COPD Home Monitoring Study
A clinical trial of Chronic Obstructive Pulmonary Disease, sponsored by Cognita Labs.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04918095: Recruiting study of Chronic Obstructive Pulmonary Disease, sponsored by Cognita Labs.
NCT04918095 is a study of Chronic Obstructive Pulmonary Disease that is actively recruiting participants, run by Cognita Labs. The registered enrollment target is 50 participants, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04918095, a study of Chronic Obstructive Pulmonary Disease, is actively recruiting participants, sponsored by Cognita Labs.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to demonstrate early validation of objective home-monitoring of Chronic obstructive pulmonary disease (COPD) patients by combining accurate and relevant patient data of medication and lung function (lung impedance) through patient-facing devices.
Conditions Studied
Interventions
- DEVICE CareCOPD Platform
Study Locations (1)
California
- Ventura County Medical Center - Ventura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2026-07-31 |
What NCT04918095 shows while recruiting
NCT04918095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which CareCOPD Platform is the first listed.
NCT04918095 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04918095 about?
NCT04918095 is a clinical study titled "CareCOPD - COPD Home Monitoring Study". This is a pilot study to demonstrate early validation of objective home-monitoring of Chronic obstructive pulmonary disease (COPD) patients by combining accurate and relevant patient data of medication and lung function (lung impedance) through patient-facing devices.
What is the current status of trial NCT04918095?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2020-11-09. Estimated completion is 2026-07-31.
What conditions does trial NCT04918095 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT04918095?
The interventions under investigation include: CareCOPD Platform (DEVICE).
Who is sponsoring clinical trial NCT04918095?
This trial is sponsored by Cognita Labs, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04918095 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04918095's enrollment target sits among peer trials
50 63rd of 86 higher than 24 of 86 other Chronic Obstructive Pulmonary Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
RECRUITING
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
COPD Care Pathway Among Patients With Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI